Tramadol (CED0001790)

Record Information
Version1.0
Creation Date2009-07-05 03:34:13 UTC
Update Date2026-05-14 16:24:35 UTC
SynCED IDCED0001790
Secondary Accession Numbers
  • CHEM002099
  • T3D2575
Identification
Common NameTramadol
ClassSmall Molecule
Description
Tramadol belongs to the anisoles, a subclass of phenol ethers within the organic compounds. It is an exogenous solid with the formula C16H25NO2 and an average molecular weight of 263.38 g/mol. As a drug (PMC6006277 ), it is used as an analgesic, opioid analgesic, and antitussive (PMC2663660 , PMC7307949 ). It is used in the treatment of pain (PMC6942774 ) and chronic pain (PMC2663660 , PMC8035696 ). Biologically, tramadol acts as a delta-opioid receptor agonist, kappa-opioid receptor agonist, mu-opioid receptor agonist, serotonin uptake inhibitor, serotonergic antagonist, adrenergic uptake inhibitor, nicotinic antagonist, muscarinic antagonist, and NMDA receptor antagonist (PMC2663660 , PMC7307949 ). It also functions as a capsaicin receptor antagonist (PMC2663660 , PMC7307949 ). Recorded protein targets include the mu-type opioid receptor (OPRM1), sodium-dependent noradrenaline transporter (SLC6A2), 5-hydroxytryptamine receptor 2C (HTR2C), and kappa-type opioid receptor (OPRK1), among others. Tramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase, subsequently inhibiting the release of nociceptive neurotransmitters. Health effects associated with tramadol include nausea, dizziness, vomiting, and headache (PMC9392978 ), as well as seizure, bradycardia, tachycardia, hypotension, and coma (PMC8035696 ). It is also associated with a decrease in hyperprolactinemia (PMC7807371 ). Exposure routes include oral, inhalation, and topical.
Contaminant Type
  • Amine
  • Analgesic
  • Analgesic, Opioid
  • Drug
  • Ether
  • Human Neurotoxin
  • Metabolite
  • Narcotic
  • Organic Compound
  • Synthetic Compound
Chemical Structure
Synonyms
ValueSource
(+)-TramadolChEBI
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanolChEBI
AmandaKegg
1a Brand OF tramadol hydrochlorideHMDB
ASTA medica brand OF tramadol hydrochlorideHMDB
AbZ brand OF tramadol hydrochlorideHMDB
AdolontaHMDB
Bayvit brand OF tramadol hydrochlorideHMDB
Bexal brand OF tramadol hydrochlorideHMDB
Dolorgiet brand OF tramadol hydrochlorideHMDB
Edigen brand OF tramadol hydrochlorideHMDB
Hexal brand OF tramadol hydrochlorideHMDB
Lindopharm brand OF tramadol hydrochlorideHMDB
MTW Brand OF tramadol hydrochlorideHMDB
MTW TramadolHMDB
Mabo brand OF tramadol hydrochlorideHMDB
Q-Pharm brand OF tramadol hydrochlorideHMDB
Rowa brand OF tramadol hydrochlorideHMDB
Theraplix brand OF tramadol hydrochlorideHMDB
Tradol-purenHMDB
TradolPurenHMDB
Trama 1a pharmaHMDB
Trama KDHMDB
Tramadol asta medicaHMDB
Tramadol bexalHMDB
Tramadol edigenHMDB
Tramadol ratiopharmHMDB
TramadolHamelnHMDB
UltramHMDB
ZydolHMDB
Alpharma brand OF tramadol hydrochlorideHMDB
BiodalgicHMDB
Byk brand OF tramadol hydrochlorideHMDB
Ciclum brand OF tramadol hydrochlorideHMDB
Cinfa brand OF tramadol hydrochlorideHMDB
Clonmel brand OF tramadol hydrochlorideHMDB
ContramalHMDB
Elerte brand OF tramadol hydrochlorideHMDB
Expanscience brand OF tramadol hydrochlorideHMDB
Hameln brand OF tramadol hydrochlorideHMDB
JutadolHMDB
Knoll brand OF tramadol hydrochlorideHMDB
Krewel brand OF tramadol hydrochlorideHMDB
MTWTramadolHMDB
Medix brand OF tramadol hydrochlorideHMDB
TAD brand OF tramadol hydrochlorideHMDB
TheradolHMDB
TiralHMDB
Tradol purenHMDB
TradonalHMDB
Trama-dorschHMDB
TramaDorschHMDB
TramadinHMDB
TramadocHMDB
Tramadol 1aHMDB
Tramadol alHMDB
Tramadol bayvitHMDB
Tramadol maboHMDB
Tramadol PBHMDB
Tramadol acisHMDB
TramadolDolgitHMDB
TramadolorHMDB
TramageticHMDB
TramagitHMDB
Zambon brand OF tramadol hydrochlorideHMDB
ZamudolHMDB
ZytramHMDB
Betapharm brand OF tramadol hydrochlorideHMDB
Aliud brand OF tramadol hydrochlorideHMDB
AmadolHMDB
CSL Brand OF tramadol hydrochlorideHMDB
Christiaens brand OF tramadol hydrochlorideHMDB
Erempharma brand OF tramadol hydrochlorideHMDB
Grunenthal brand OF tramadol hydrochlorideHMDB
Heumann brand OF tramadol hydrochlorideHMDB
Juta brand OF tramadol hydrochlorideHMDB
Kern brand OF tramadol hydrochlorideHMDB
Lakeside brand OF tramadol hydrochlorideHMDB
Lichtenstein brand OF tramadol hydrochlorideHMDB
Mundipharma brand OF tramadol hydrochlorideHMDB
NobliganHMDB
Ortho brand OF tramadol hydrochlorideHMDB
Ranitidin 1a pharmaHMDB
Ratiopharm brand OF tramadol hydrochlorideHMDB
Searle brand OF tramadol hydrochlorideHMDB
Stadapharm brand OF tramadol hydrochlorideHMDB
TakadolHMDB
TopalgicHMDB
TradolHMDB
TralgiolHMDB
Trama abzHMDB
Tramadol hydrochlorideHMDB
Tramadol normonHMDB
Tramadol-hamelnHMDB
Tramadol-ratiopharmHMDB
TramadolratiopharmHMDB
TramakeHMDB
TrasedalHMDB
Viatris brand OF tramadolHMDB
Acis brand OF tramadol hydrochlorideHMDB
Allphar brand OF tramadol hydrochlorideHMDB
Antigen brand OF tramadol hydrochlorideHMDB
Azupharma brand OF tramadol hydrochlorideHMDB
Basics brand OF tramadol hydrochlorideHMDB
Biocodex brand OF tramadol hydrochlorideHMDB
BiokanolHMDB
Docpharm brand OF tramadol hydrochlorideHMDB
Janssen brand OF tramadol hydrochlorideHMDB
Kade brand OF tramadol hydrochlorideHMDB
MTW-TramadolHMDB
Merck dura brand OF tramadol hydrochlorideHMDB
Normon brand OF tramadol hydrochlorideHMDB
ProntofortHMDB
Q Pharm brand OF tramadol hydrochlorideHMDB
Trama dorschHMDB
TramabetaHMDB
Tramadol basicsHMDB
Tramadol cinfaHMDB
Tramadol dolgitHMDB
Tramadol hamelnHMDB
Tramadol heumannHMDB
Tramadol kernHMDB
Tramadol lichtensteinHMDB
Tramadol lindoHMDB
Tramadol stadaHMDB
Tramadol viatris brandHMDB
Tramadol-dolgitHMDB
TramaduraHMDB
TramalHMDB
TramexHMDB
TramundinHMDB
Xymel 50HMDB
ZumalgicHMDB
Chemical FormulaC16H25NO2
Average Molecular Mass263.375 g/mol
Monoisotopic Mass263.189 g/mol
CAS Registry Number27203-92-5
IUPAC Name(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol
Traditional Nametramadol
SMILESCOC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
InChI IdentifierInChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3/t14-,16+/m1/s1
InChI KeyTVYLLZQTGLZFBW-ZBFHGGJFSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof.
KingdomOrganic compounds
Super ClassBenzenoids
ClassPhenol ethers
Sub ClassAnisoles
Direct ParentAnisoles
Alternative Parents
Substituents
  • Phenoxy compound
  • Anisole
  • Methoxybenzene
  • Alkyl aryl ether
  • Cyclohexanol
  • Aralkylamine
  • Monocyclic benzene moiety
  • Tertiary alcohol
  • Cyclic alcohol
  • Tertiary aliphatic amine
  • Tertiary amine
  • Ether
  • Organooxygen compound
  • Organonitrogen compound
  • Organopnictogen compound
  • Alcohol
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
  • 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol (CHEBI:75725 )
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceSolid (1).
Experimental Properties
PropertyValue
Melting Point180-181°C
Boiling PointNot Available
SolubilitySoluble
Predicted Properties
PropertyValueSource
Water Solubility0.75 g/LALOGPS
logP2.71ALOGPS
logP2.45ChemAxon
logS-2.6ALOGPS
pKa (Strongest Acidic)13.8ChemAxon
pKa (Strongest Basic)9.23ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area32.7 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity78.27 m³·mol⁻¹ChemAxon
Polarizability30.45 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0a4i-9650000000-250d842ef06233328170Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-05fr-5193000000-dd2e84f70a47d0634c43Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-1550dc2447717d7d8728Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-7850be0ba78033f1f677Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-62a3c5cb6717bff20e2cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05fs-0930000000-b8297a71c45e9630f6c0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05fr-0900000000-f650c49b70db20869d0fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0adl-0900000000-b17dfc32e2eb57efaf42Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-c35bec467cfec28511fbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-1090000000-9ca08dcdc5a2027bcb03Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9030000000-469467d2583e7202d89fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-89f055b497c88cdc5e79Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-1922068301c6d3b4f457Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-1922068301c6d3b4f457Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-5a9396f20ce15b9c08baNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-1090000000-e040861e9fa18a8f44a5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9030000000-fa1522b6a491e6da41c9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-8ab0ebc3ceff7c5e5ce5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-7645dc9b29d8b2867495Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-70cad0a31ff2d57bab81Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-bf1b2c15c6511355c9e1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-02e5642feacadbc07dbaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0abi-0900000000-5e83a9ee1a223ef36905Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0900000000-56f60436c6df4aeb6515Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-1336e1f66542750cc1deNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-0f15435bd2e7f629a898Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-1550dc2447717d7d8728Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-1090000000-09efdf3305045c24a6d5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9030000000-469467d2583e7202d89fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-1090000000-42ca043ada6b5a62a8aeNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-c35bec467cfec28511fbNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-0bc53c20c7d80cdbb09cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9030000000-2b847462e3ce1b19e8daNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-62a3c5cb6717bff20e2cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-02e5642feacadbc07dbaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-7850be0ba78033f1f677Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05fs-0930000000-b8297a71c45e9630f6c0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-1336e1f66542750cc1deNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0090000000-0f15435bd2e7f629a898Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-05fr-0900000000-f650c49b70db20869d0fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-70cad0a31ff2d57bab81Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0adl-0900000000-b17dfc32e2eb57efaf42Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-b93e0bbb1dd70ba2921cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-9000000000-c589518a9ccd2d20aed5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ot-0090000000-7fe9a41fb060355ba0c0Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0hft-1190000000-8c3c0de6df7ced23802aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0pbc-9120000000-4f0e74f6721de4ccf067Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0090000000-24bef5bd2510914bee83Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-1490000000-3314217686d7d48bff0dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4l-9380000000-76c818434cc5aeed5acaNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0bt9-8090000000-91857254cb7046ab9ee5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9110000000-8fcf109eb623dcf29297Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9000000000-de79da9b9e90d38bef16Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0190000000-a1a72dd22669449301f8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-0190000000-0b17949f2da7bdbc7943Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-1900000000-635141b8e3e9e3312f28Not AvailableView Spectrum
MSMS Spectrumsplash10-0a4i-9010000000-ffea37e400f0860f2e7fNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
300.0 mg/kg [300:350]RatLD50OralexperimentalNot Available7
224.0 Log mg/kg [130:400]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelNot Available
SymptomsOverdose symptoms of a tramadol overdose may include drowsiness, shallow breathing, slow heartbeat, extreme weakness, cold or clammy skin, feeling light-headed, fainting, or coma. (9)
TreatmentIn treating an overdose, primary attention should be given to maintaining adequate ventilation along with general supportive treatment. While naloxone will reverse some, but not all, symptoms caused by overdosage with ULTRAM, the risk of seizures is also increased with naloxone administration. (10)
Health Effects
Health EffectRelationshipDirectionDescriptionReference
inflammationNot AvailableNot AvailableNot AvailablePMC10178540
drowsinessAssociated With?Not AvailableA state of sleepiness or lethargy.PMC9392978
dizzinessAssociated With?Not AvailableA sensation of lightheadedness, unsteadiness, turning, spinning or rocking.PMC9392978 , PMC11232794
dizzinessAssociated With?increaseA sensation of lightheadedness, unsteadiness, turning, spinning or rocking.PMC13409903
breast cancerHas Therapeutic Effect OnNot AvailableA breast cancer that has material basis in abnormally proliferating cells derives from epithelial cells. (DO)PMC10031984
painNot AvailableNot AvailableA disorder characterized by the sensation of marked discomfort, distress or agony. (NCI CTCAE)PMC6942774 , PMC12088781
painHas Therapeutic Effect OnNot AvailableA disorder characterized by the sensation of marked discomfort, distress or agony. (NCI CTCAE)PMC12393813 , PMC11232794
headacheAssociated With?Not AvailableA disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve. (NCI CTCAE)PMC9392978
headacheAssociated With?increaseA disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve. (NCI CTCAE)PMC13409903
headacheNot AvailableNot AvailableA disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve. (NCI CTCAE)PMC8847594
chronic painNot AvailableNot AvailableA state in which pain lasts for several weeks or months and may increase in severity.PMC2663660 , PMC8035696
nauseaAssociated With?Not AvailableA disorder characterized by a queasy sensation and/or the urge to vomit. (NCI CTCAE)PMC9392978 , PMC11232794
nauseaAssociated With?increaseA disorder characterized by a queasy sensation and/or the urge to vomit. (NCI CTCAE)PMC13409903
vomitingAssociated With?Not AvailableA disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. (NCI CTCAE)PMC9392978 , PMC11232794
vomitingAssociated With?increaseA disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. (NCI CTCAE)PMC13409903
seizureAssociated With?Not AvailableNot AvailablePMC8035696 , PMC8035696
hypoglycemiaAssociated With?Not AvailableA disorder characterized by laboratory test results that indicate a low concentration of glucose in the blood. (NCI CTCAE)PMC9323855
hypotensionAssociated With?Not AvailableA disorder characterized by a blood pressure that is below the normal expected for an individual in a given environment. (NCI CTCAE)PMC8035696
hyperprolactinemiaAssociated With?decreaseHyperprolactinemia is the abnormal elevation of serum prolactin level. Prolactin is a peptide hormone produced by the anterior pituitary gland that is primarily associated with lactation and plays a vital role in breast development during pregnancy. Hyperprolactinaemia may cause galactorrhea (production and spontaneous flow of breast milk), infertility, and disruptions in the normal menstrual period in women; and hypogonadism, infertility and erectile dysfunction in men. Hyperprolactinemia can be caused by prolactinoma (a type of pituitary adenoma)., which accounts for 40% of pituitary cancers. Other causes include chronic kidney failure, hypothyroidism, bronchogenic carcinoma and sarcoidosis. Some women with polycystic ovary syndrome may have mildly-elevated prolactin levels.PMC7807371
bradycardiaAssociated With?Not AvailableNot AvailablePMC8035696
tachycardiaAssociated With?Not AvailableA disorder characterized as a type of heart rhythm disorder in which the heart beats faster than normal while at rest.PMC8035696
comaAssociated With?Not AvailableA state of profound unconsciousness associated with markedly depressed cerebral activity. Causes include central nervous system damage, intoxication, and metabolic abnormalities.PMC8035696
brain diseaseAssociated With?Not AvailableNot AvailablePMC9323855
Weight lossAssociated With?Not AvailableNot AvailablePMC9734374
PoisoningAssociated With?Not AvailableNot AvailablePMC8035696
constipation disorderAssociated With?Not AvailableNot AvailablePMC9392978
ApneaAssociated With?Not AvailableNot AvailablePMC8035696
XerostomiaAssociated With?decreaseNot AvailablePMC10535338
hypotensive disorderAssociated With?Not AvailableNot AvailablePMC8035696 , PMC9323855
Bone painNot AvailableNot AvailableNot AvailablePMC11382656
lightheadednessAssociated With?increaseNot AvailablePMC13409903
Hypergonadotropic hypogonadismAssociated With?decreaseNot AvailablePMC7807371
BradypneaAssociated With?Not AvailableNot AvailablePMC9323855
Brain DeathAssociated With?Not AvailableNot AvailablePMC9323855
Exposure Sources
Source IDSourceSectorReference
CEDs000010Insecticides?Insecticides are synthetic chemicals designed to control or eliminate insect pests that threaten crops and other agricultural products.Agriculture & land managementPubChem
CEDs000019Indoor air?Indoor air can be a significant reservoir for synthetic chemical contaminants, which often originate from various sources within enclosed environments.Air, dust & atmospheric transportNot Available
CEDs000051Surface water?Surface water can serve as a significant vector for the introduction of synthetic chemical contaminants into aquatic ecosystems.Aquatic systems & sedimentsPMC13400670 , PMC10114791
CEDs000115Drinking water?Drinking water can be a medium for synthetic chemical contamination, often originating from various industrial processes and agricultural practices.Drinking water & water supplyPMC7075194
CEDs000370Analgesics?Analgesics are a class of synthetic chemicals designed to alleviate pain.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000479Effluent?Effluent refers to liquid waste or sewage that is discharged into the environment, typically resulting from industrial processes, municipal wastewater treatment, or agricultural runoff.Wastewater, sanitation & biosolidsPMC6965340
CEDs000482WWTP influent?WWTP influent refers to the raw wastewater entering a wastewater treatment plant, which can contain a complex mixture of pollutants, including synthetic chemicals.Wastewater, sanitation & biosolidsPMC12031460
CEDs000496Fencing?Fencing materials, particularly those used in construction and landscaping, can be a source of synthetic chemical contamination due to the treatments and coatings applied for durability and weather resistance.Building & ConstructionPubChem
CEDs000498Ladders?Ladders, commonly used in various construction and maintenance activities, can become a source of synthetic chemical contamination due to the materials and coatings applied during their manufacture and use.Building & ConstructionPubChem
CEDs000499Roofs?Roofs can be a significant source of synthetic chemical contamination due to the materials used in their construction and maintenance.Building & ConstructionPubChem
CEDs000503Tents Or Canopies?Tents and canopies used in various applications can be a source of synthetic chemical contamination primarily due to the materials from which they are made.Building & ConstructionPubChem
CEDs000506Antennas?Antennas, commonly used in communication technologies, can be a source of synthetic chemical contamination through the materials and coatings used in their construction.Electrical & Electronic EquipmentPubChem
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000517Electric Switches?Electric switches, integral components in numerous devices, can be a source of synthetic chemical contamination due to the materials and manufacturing processes involved in their production.Electrical & Electronic EquipmentPubChem
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000520Emergency Protective Devices?Emergency protective devices, such as circuit breakers and surge protectors, are essential components in electrical systems designed to prevent damage from overcurrent and surges.Electrical & Electronic EquipmentPubChem
CEDs000524Hybrid Capacitors?Hybrid capacitors are energy storage devices that combine the properties of electrolytic and supercapacitors, utilizing a combination of electrochemical principles to achieve higher energy density and power density.Electrical & Electronic EquipmentPubChem
CEDs000531Relays?Relays are electromechanical switches used to control circuits and manage electrical loads.Electrical & Electronic EquipmentPubChem
CEDs000537Television Systems?Television systems can be a source of synthetic chemical contamination due to the various materials and components used in their manufacture and operation.Electrical & Electronic EquipmentPubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000549Preparation Of Wine Or Sparkling Wine?The preparation of wine or sparkling wine involves various stages, including fermentation, aging, and bottling, which can introduce potential sources of synthetic chemical contamination.Food, food processing & cookwarePubChem
CEDs000552Processing Meats?Processing meats can lead to synthetic chemical contamination primarily through the use of additives and preservatives.Food, food processing & cookwarePubChem
CEDs000555Bleaching Agents?Bleaching agents are chemical substances used to whiten or lighten materials, often employed in various cleaning products for their stain removal and disinfecting properties.Household cleaning & consumer productsPubChem
CEDs000556Cigar Cigarettes?Cigar cigarettes are a source of synthetic chemical contamination due to the combustion of various tobacco blends and additives.Household cleaning & consumer productsPubChem
CEDs000559Non Electric Simulated Smoking Devices?Non-electric simulated smoking devices, often designed to mimic the experience of smoking without combustion, can be sources of synthetic chemical contamination due to the materials and chemicals used in their construction and operation.Household cleaning & consumer productsPubChem
CEDs000560Other Smoking Requisites?Other smoking requisites, including items such as lighters, matches, and rolling papers, can introduce synthetic chemical contamination through various components and additives.Household cleaning & consumer productsPubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000569Tobacco Smoke Filters?Tobacco smoke filters are designed to reduce the inhalation of harmful substances in cigarette smoke, including tar and other particulate matter.Household cleaning & consumer productsPubChem
CEDs000580Manufacture Preparation Of Tobacco Products?The manufacture and preparation of tobacco products involve various processes that can result in the introduction of synthetic chemicals into the environment.Industrial manufacturing & chemical processingPubChem
CEDs000581Paper Making Machines?Paper making machines utilize various synthetic chemicals throughout the production process, including additives, coatings, and bleaching agents.Industrial manufacturing & chemical processingPubChem
CEDs000596Acaricides?Acaricides are synthetic chemicals specifically designed to target and control mite populations that can damage crops and plants.Agriculture & land managementPubChem
CEDs000600Herbicides And Algicides?Herbicides and algicides are synthetic chemicals primarily used to control unwanted plants and algae in various environments.Agriculture & land managementPubChem
CEDs000602Molluscicides?Molluscicides are synthetic chemicals specifically designed to control and eliminate mollusks, such as snails and slugs, which can be detrimental to crops and agricultural productivity.Agriculture & land managementPubChem
CEDs000603Nematocides?Nematocides are synthetic chemicals specifically designed to control nematodes, which are microscopic roundworms that can cause significant damage to crops and plants.Agriculture & land managementPubChem
CEDs000605Pest Repellants?Pest repellents, often formulated from synthetic chemicals, are widely used to protect crops from insect infestations and other pests.Agriculture & land managementPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000617Lip Care Products?Lip care products, including lipsticks, balms, and glosses, often contain a variety of synthetic chemicals such as parabens, phthalates, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000630Toys?Toys, particularly those made from synthetic materials such as plastics, can be a source of chemical contamination due to the presence of various additives and compounds used in their production.Recreation & sports surfacesPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000635Buttons?Buttons, often made from synthetic materials such as polyester, nylon, or polycarbonate, can be a source of synthetic chemical contamination during their production, use, and disposal.Textiles, leather & furnishingsPubChem
CEDs000642Footwear?Footwear production often involves the use of various synthetic chemicals, such as adhesives, dyes, and treatments, which can contribute to environmental contamination.Textiles, leather & furnishingsPubChem
CEDs000643Headwear?Headwear made from synthetic materials often incorporates chemicals used in the manufacturing and finishing processes, such as dyes, flame retardants, and water repellents.Textiles, leather & furnishingsPubChem
CEDs000649Pins Clothes?Pins Clothes can serve as a potential source of synthetic chemical contamination due to the use of various synthetic fibers and finishes in textile production.Textiles, leather & furnishingsPubChem
CEDs000650Purses Luggage Hand Bags?Purses, luggage, and handbags are often manufactured using synthetic materials such as polyvinyl chloride (PVC), polyurethane, and various types of nylon.Textiles, leather & furnishingsPubChem
CEDs000651Purses Money Bags Wallets?Purses, money bags, and wallets are often manufactured using synthetic materials, including plastics, polyurethanes, and various treated fabrics.Textiles, leather & furnishingsPubChem
CEDs000653Sewing?Sewing processes often involve the use of various synthetic chemicals, which can become sources of contamination in the environment.Textiles, leather & furnishingsPubChem
CEDs000656Snap Fasteners?Snap fasteners, commonly used in clothing and upholstery, can be made from various synthetic materials, including plastics and metal alloys.Textiles, leather & furnishingsPubChem
CEDs000659Transfer Printing?Transfer printing is a process used to apply designs and patterns onto various substrates, commonly utilizing synthetic dyes and inks that can contain hazardous chemicals.Textiles, leather & furnishingsPubChem
CEDs000662Yarns Or Threads?Yarns or threads used in textiles can be a source of synthetic chemical contamination due to the production processes and treatments they undergo.Textiles, leather & furnishingsPubChem
CEDs000671Airplanes And Helicopters?Airplanes and helicopters are significant sources of synthetic chemical contamination primarily through the use of aviation fuels, lubricants, and de-icing agents.Aviation & AerospacePubChem
CEDs000678Nitrogenous Fertilisers?Nitrogenous fertilizers are synthetic chemical compounds primarily used to enhance plant growth by supplying essential nitrogen, a crucial nutrient for photosynthesis and protein synthesis.Agriculture & land managementPubChem
CEDs000679Phosphatic Fertilisers?Phosphatic fertilizers are synthetic chemical products primarily composed of phosphorus, which is essential for plant growth.Agriculture & land managementPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000688Glass Coatings?Glass coatings are synthetic chemical formulations applied to glass surfaces to enhance properties such as durability, UV resistance, and aesthetic appeal.Building & ConstructionPubChem
CEDs000693Silica Glass?Silica glass, primarily composed of silicon dioxide (SiO2), is widely used in various applications, including windows, glass facades, and insulation materials.Building & ConstructionPubChem
CEDs000695Treatment Of Milk Or Cream?The treatment of milk or cream involves various processes such as pasteurization, homogenization, and the addition of preservatives to enhance shelf life and safety.Food, food processing & cookwarePubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000699Mining Or Quarrying?Mining and quarrying operations can lead to synthetic chemical contamination through the release of various pollutants associated with the extraction and processing of minerals.Mining & metal processingPubChem
CEDs000707Books?Books can be a source of synthetic chemical contamination due to the use of various chemicals in their production and preservation processes.Paper, pulp & fiber productsPubChem
CEDs000727Printing Machines Or Presses?Printing machines or presses commonly utilize synthetic chemicals such as inks, solvents, and cleaning agents.Paper, pulp & fiber productsPubChem
CEDs000729Stamps?Stamps, particularly those produced using synthetic inks and adhesives, can contribute to chemical contamination when disposed of improperly.Paper, pulp & fiber productsPubChem
CEDs000735Explosives?Explosives are chemical compounds or mixtures designed to undergo rapid decomposition, releasing energy in the form of gas and heat.Defense & military infrastructurePubChem
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
CEDs000741Pigment Pastes?Pigment pastes are concentrated dispersions of pigments used to impart color and properties to materials.Paper, pulp & fiber productsPubChem
CEDs000743Sludge Treatment?Sludge treatment involves the processing of waste materials generated from wastewater treatment plants, which often contain a variety of organic and inorganic substances.Wastewater, sanitation & biosolidsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs00812FieldAgriculture & land managementPMC11833869
CEDs01081TabletsHealthcare, pharmaceuticals & veterinary productsPMC9609301
CEDs01171MeatFood, food processing & cookwarePMC13250117
CEDs02255WaterAquatic systems & sedimentsPMC12863633 , PMC12863633
CEDs02268Water SamplesAquatic systems & sedimentsPMC12863633
CEDs02269Natural WatersAquatic systems & sedimentsPMC9734374
CEDs02270RiverAquatic systems & sedimentsPMC6412430 , PMC6412430
CEDs02286LakeAquatic systems & sedimentsPMC6412430 , PMC6412430
CEDs03009Waste WaterWastewater, sanitation & biosolidsPMC11535420 , PMC5674211
CEDs03013EffluentsWastewater, sanitation & biosolidsPMC6412430 , PMC6412430
CEDs03021Wastewater Treatment PlantWastewater, sanitation & biosolidsPMC6412430
CEDs03037WWTP effluentsWastewater, sanitation & biosolidsPMC6006277
CEDs03039Influent WastewaterWastewater, sanitation & biosolidsPMC7456777
CEDs03050Sludge SamplesWastewater, sanitation & biosolidsPMC12444985
CEDs03091WWTPs effluentsWastewater, sanitation & biosolidsPMC11570933
CEDs03097Secondary EffluentsWastewater, sanitation & biosolidsPMC8538421
CEDs03125Treated EffluentsWastewater, sanitation & biosolidsPMC6965340
Pathways
5 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)
Prediction Confidence Score
0.629
Applicability Domain
1.0
Statistical Significance
0.0019
Supporting Reference Compounds
527
E-value
14.7914
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)
Prediction Confidence Score
0.62
Applicability Domain
1.0
Statistical Significance
5.80e-04
Supporting Reference Compounds
593
E-value
4.51525
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)
Prediction Confidence Score
0.617
Applicability Domain
1.0
Statistical Significance
2.50e-04
Supporting Reference Compounds
451
E-value
1.94623
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)
Prediction Confidence Score
0.61
Applicability Domain
1.0
Statistical Significance
0.0026
Supporting Reference Compounds
427
E-value
20.5522
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)
Prediction Confidence Score
0.555
Applicability Domain
1.0
Statistical Significance
0.0054
Supporting Reference Compounds
532
E-value
41.8829
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.495
Applicability Domain
1.0
Statistical Significance
0.0091
Supporting Reference Compounds
229
E-value
70.6092
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP42866Mus musculusPredicted (SEA)
Prediction Confidence Score
0.461
Applicability Domain
0.717
Statistical Significance
0.0042
Supporting Reference Compounds
107
E-value
32.7745
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.323
Applicability Domain
0.357
Statistical Significance
0.0197
Supporting Reference Compounds
297
E-value
153.207
Click to view 3D structureAlpha-1A adrenergic receptorP43140Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.316
Applicability Domain
0.357
Statistical Significance
0.0166
Supporting Reference Compounds
208
E-value
129.463
Click to view 3D structureNorepinephrine transporterQ9WTR4Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.301
Applicability Domain
0.357
Statistical Significance
0.0104
Supporting Reference Compounds
112
E-value
80.9632
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.301
Applicability Domain
0.357
Statistical Significance
0.0517
Supporting Reference Compounds
541
E-value
402.792
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.296
Applicability Domain
0.358
Statistical Significance
0.0679
Supporting Reference Compounds
562
E-value
528.44
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)
Prediction Confidence Score
0.285
Applicability Domain
0.357
Statistical Significance
0.0608
Supporting Reference Compounds
506
E-value
473.479
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)
Prediction Confidence Score
0.281
Applicability Domain
0.317
Statistical Significance
0.1874
Supporting Reference Compounds
1130
E-value
1458.74
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)
Prediction Confidence Score
0.281
Applicability Domain
0.317
Statistical Significance
0.0801
Supporting Reference Compounds
528
E-value
623.339
Click to view 3D structureTransporterQ63380Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.279
Applicability Domain
0.357
Statistical Significance
0.0072
Supporting Reference Compounds
54
E-value
55.74
Click to view 3D structureSigma non-opioid intracellular receptor 1Q60492Cavia porcellusPredicted (SEA)
Prediction Confidence Score
0.279
Applicability Domain
0.317
Statistical Significance
0.0555
Supporting Reference Compounds
229
E-value
432.452
Click to view 3D structureSigma non-opioid intracellular receptor 1Q9R0C9Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.278
Applicability Domain
0.317
Statistical Significance
0.038
Supporting Reference Compounds
207
E-value
295.593
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.276
Applicability Domain
0.317
Statistical Significance
0.153
Supporting Reference Compounds
1103
E-value
1191.33
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP14842Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.276
Applicability Domain
0.357
Statistical Significance
0.0682
Supporting Reference Compounds
380
E-value
530.62
Click to view 3D structureSodium-dependent dopamine transporterP23977Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.276
Applicability Domain
0.357
Statistical Significance
0.0338
Supporting Reference Compounds
203
E-value
263.52
Muscarinic acetylcholine receptor M2 structureClick to view 3D structureMuscarinic acetylcholine receptor M2P08172HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.358
Statistical Significance
0.0617
Supporting Reference Compounds
373
E-value
480.096
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)
Prediction Confidence Score
0.271
Applicability Domain
0.304
Statistical Significance
0.2993
Supporting Reference Compounds
1245
E-value
2330.03
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)
Prediction Confidence Score
0.269
Applicability Domain
0.304
Statistical Significance
0.3706
Supporting Reference Compounds
1538
E-value
2885.01
Muscarinic acetylcholine receptor M3 structureClick to view 3D structureMuscarinic acetylcholine receptor M3P20309HumansPredicted (SEA)
Prediction Confidence Score
0.267
Applicability Domain
0.358
Statistical Significance
0.0636
Supporting Reference Compounds
310
E-value
495.432
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansKnownNot Available
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansKnownNot Available
Glutathione reductase structureClick to view 3D structureGlutathione reductaseP06715Escherichia coli (strain K12)KnownNot Available
Glutathione S-transferase structureClick to view 3D structureGlutathione S-transferaseQ59721Burkholderia xenovorans (strain LB400)KnownNot Available
Catalase structureClick to view 3D structureCatalaseP04040HumansKnownNot Available
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansKnownTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansKnownTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
Muscarinic acetylcholine receptor M3 structureClick to view 3D structureMuscarinic acetylcholine receptor M3P20309HumansKnownNot Available
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansKnownTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansKnownTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
Click to view 3D structureAlpha-7 nicotinic cholinergic receptor subunitQ693P7HumansKnownNot Available
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansKnownNot Available
Glutamate receptor ionotropic, NMDA 3A structureClick to view 3D structureGlutamate receptor ionotropic, NMDA 3AQ8TCU5HumansKnownNot Available
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansKnownTramadol and its O-desmethyl metabolite (M1) are selective, weak OP3-receptor agonists. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. The analgesic properties of Tramadol can be attributed to norepinephrine and serotonin reuptake blockade in the CNS, which inhibits pain transmission in the spinal cord. The (+) enantiomer has higher affinity for the OP3 receptor and preferentially inhibits serotonin uptake and enhances serotonin release. The (-) enantiomer preferentially inhibits norepinephrine reuptake by stimulating alpha(2)-adrenergic receptors.
Concentrations
StatusValueUnitSample LocationReference
External Links
DrugBank IDDB00193
HMDB IDHMDB0014339
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkTramadol
Chemspider ID31105
ChEBI ID75725
PubChem Compound ID33741
Kegg Compound IDC07153
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis Reference

Wolfgang Reimann, “Combination preparation containing tramadol and a calcium channel antagonist.” U.S. Patent US5929122, issued March, 1993.

MSDSLink
General References
  1. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. [PubMed: 18048412]
  2. Dayer P, Desmeules J, Collart L: [Pharmacology of tramadol]. Drugs. 1997;53 Suppl 2:18-24. [PubMed: 9190321]
  3. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M: Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998 Jun;50(6):1842-6. [PubMed: 9633738]
  4. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M: Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000 Mar-Apr;14(2):65-70. [PubMed: 10959067]
  5. Gobel H, Stadler T: [Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine]. Drugs. 1997;53 Suppl 2:34-9. [PubMed: 9190323]
  6. Boureau F, Legallicier P, Kabir-Ahmadi M: Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003 Jul;104(1-2):323-31. [PubMed: 12855342]
  7. Matthiesen T, Wohrmann T, Coogan TP, Uragg H: The experimental toxicology of tramadol: an overview. Toxicol Lett. 1998 Mar 16;95(1):63-71. [PubMed: 9650647]
  8. Wikipedia. Tramadol. Last Updated 8 August 2009. - http://en.wikipedia.org/wiki/Tramadol
  9. Drugs.com - http://www.drugs.com/cons/Tramadol.html
  10. RxList: The Internet Drug Index (2009). - http://www.rxlist.com/
  11. FDA label